Indian pharma firms receive 34% of FDA warnings this year

These warnings were for misbranding, selling unapproved medicines and violating Current Good Management Practices

Profits and not improving accessibility matter to Indian drug makers

FICCI conference organised to discuss access to generic medicines focuses more on increasing exports

Curing the ills of pharma FDI

Foreign investment in existing pharma companies will be allowed with riders

Diabetes drug ban spells trouble for patients, doctors

Experts say pioglitazone difficult to substitute and health ministry has imposed ban without a back up plan

Predatory EU pacts

EU is pushing India and Canada to sign free trade agreements that will hurt their generic drugs—and the outrage is global

‘PESTICIDES’ IN DRUGS

Sharad Pawar’s provision for protecting test data in the Pesticides Bill could spill over into trade agreements and hit the drugs industry, too

US piles on the pressure

Patent law, domestic content rules in solar and ICT policy come under attack

Novartis loses patent appeal in landmark suit

Supreme Court upholds amended law that bars patents for insignificant improvements to an existing drug—in this case anti-cancer drug …